The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Who’s Going to Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

126 organizations and 107 speakers at Festival of Biologics USA 2027, a ~2,000-person, mostly industry meeting of biologics developers and manufacturers. As of Oct 15, 2026.

Showing 1–13 of 126 organizations

Organization	Festival of Biologics USA 2027 Attendance
Pfizer New York, NY
pfizer.com Large pharma Develops and markets medicines and vaccines in oncology, inflammation and immunology, rare diseases and internal medicine.	Talk Tue Apr 13 12:00 Protein Engineering: title to be announced Talk Tue Apr 13 13:50 Vector construction for protein expression Bioprocessing Talk Tue Apr 13 14:30 Polysaccharide drug substance production: Optimization and scale-up of purification unit operations Bioprocessing Talk Tue Apr 13 15:10 Process characterization and purification of proteins Bioprocessing Also Presenting at the meeting, beyond the sessions above
AbbVie North Chicago, IL
abbvie.com Large pharma Develops and markets medicines in immunology, oncology, neuroscience and eye care, plus aesthetics.	Talk Tue Apr 13 11:40 Predictive frameworks to improve drug discovery AI & Data Talk Tue Apr 13 13:50 Biophysical characterisation and analytics of novel proteins Manufacturing Talk Wed Apr 14 11:40 Using AI ML to make Biobetters AI & Data Talk Wed Apr 14 14:00 Protein generation to support exploratory immunology Protein Engineering
Bristol Myers Squibb Princeton, NJ
bms.com Large pharma Develops and markets medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience, including cell therapies.	Talk Tue Apr 13 15:10 Downstream operations for protein purification Protein Engineering Talk Tue Apr 13 17:20 A Roadmap for Actionable AI usage AI & Data Talk Wed Apr 14 13:20 Analytical development of novel antibodies CMC Talk Wed Apr 14 15:00 Engineering Next-Generation T-Cell Engagers for Solid Tumors How adding a second activating signal to antibodies that link T cells to tumor cells could strengthen and prolong attacks on solid tumors.
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Develops and markets medicines in oncology, cardiovascular, renal, respiratory, immunology and rare diseases.	Talk Wed Apr 14 13:20 Advances in antibody-radioconjugate technology Armed Antibodies Talk Wed Apr 14 14:20 Advances in high throughput screening technologies for antibody production Protein Engineering Talk Wed Apr 14 14:40 Unnatural Precision: Site-specific conjugation for next generation ADCs How choosing where and how drugs attach to antibodies yields stabler antibody–drug conjugates and ones that carry two different drugs.
Merck Rahway, NJ
merck.com Large pharma Develops and markets medicines and vaccines, including the cancer immunotherapy Keytruda; known as MSD outside the US and Canada.	Talk Tue Apr 13 12:00 Continuous downstream processing advances Bioprocessing Talk Wed Apr 14 14:40 De novo designs for recombinant antibodies Protein Engineering Also Presenting at the meeting, beyond the sessions above
Eli Lilly Indianapolis, IN
lilly.com Large pharma Develops and markets medicines for diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Apr 13 11:00 Antibody discovery against GPCRs & antibodies as tools for small molecule discovery. Antibodies for Immunotherapy Talk Wed Apr 14 14:40 From Propagation to Push-Button: Ready-to-Use Cells and Robotic Liquid Handling in Bioassay QC Lab How frozen ready-to-use cells and pipetting robots make the cell-based tests that check biologic drug batches more consistent and less manual.
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company in the Roche Group developing medicines for cancer, immunology, neuroscience and other serious diseases.	Talk Tue Apr 13 15:10 Exploring costimulatory receptors CD28 and 4-1BB for cancer immunotherapy Antibodies for Immunotherapy Talk Wed Apr 14 13:20 Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Protein Engineering
Gilead Sciences Foster City, CA
gilead.com Large pharma Develops and markets medicines for HIV, liver disease, inflammation and cancer, including cell therapies through Kite.	Talk Tue Apr 13 15:10 Engineering challenges in manufacturing ADCs Manufacturing Talk Wed Apr 14 11:20 Beginning with the End in Mind: Using the Target Product Profile to Guide Biologics Drug Product Development CMC
Rondo Therapeutics
rondotx.com Biotech Clinical-stage developer of immune cell-engaging bispecific antibodies, including CD28 costimulatory bispecifics, for solid tumors.	Talk Tue Apr 13 13:50 Maximizing the power of bispecific therapies for treating solid tumors Antibodies for Immunotherapy Talk Tue Apr 13 14:30 Engineering CD28-based Costimulatory Bispecific Antibody Platform for the Treatment of Solid Tumors Protein Engineering
UC San Diego San Diego, CA
	Talk Tue Apr 13 13:50 Bioprocessing to make biosimilars accessible Biosimilars Talk Tue Apr 13 16:40 Leveraging AI in Computational Medicine AI & Data
University of Pennsylvania Philadelphia, PA
	Talk Tue Apr 13 13:50 AI driven trial design and optimization AI & Data Talk Tue Apr 13 13:50 Engineering protein scaffolds for novel bispecific antibodies Protein Engineering
AIVITA Biomedical Irvine, CA
aivitabiomedical.com Biotech Develops personalized vaccines for cancer and infectious diseases from an autologous cell platform.	Keynote Tue Apr 13 10:10 Keynote Panel Discussion: AI in Biologics: Progress, Limits, and What Comes Next, sponsored by Cradle Keynotes AI & data Talk Wed Apr 14 13:20 An autologous platform for production of novel Cell and Immunotherapies Advanced Therapies
CIC Cambridge, MA
cic.com Consulting & services Runs innovation campuses with offices, labs and event space for startups, plus programs connecting them with partners.	Talk Tue Apr 13 15:30 No one builds alone - How to create the best community, support systems, and teams Advice on building your network and support system before you need them, and on hiring slowly to get early teammates right. Panel Wed Apr 14 15:40 Panel Discussion: From Bench to Bedside: Overcoming CGT Commercialization Hurdles Advanced Therapies

Instantly find 20 buyers from companies at Festival of Biologics USA 2027

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where is Festival of Biologics USA 2027?

Festival of Biologics USA 2027 runs April 13–14, 2027, at the Thomas M. Menino Convention & Exhibition Center in Boston, MA.

Where is the Festival of Biologics USA 2027 program?

This guide lists every organization on the Festival of Biologics USA 2027 program with its sessions; the full program is on the official website.

How do I register for Festival of Biologics USA 2027?

Fees and registration are on the organizer's registration page.

What conference is this?

Festival of Biologics USA is Terrapinn’s US biologics meeting, held April 13–14, 2027 at the Thomas M. Menino Convention & Exhibition Center in Boston. It brings together antibody and protein engineers, bioprocess, manufacturing and CMC teams, clinical developers and biosimilar makers from pharma and biotech with the CDMOs, CROs and suppliers that serve them, across tracks on protein engineering, mAbs, AI and data, armed antibodies, antibodies for immunotherapy, oncology, advanced therapies, bioprocessing, manufacturing, CMC, clinical trials and biosimilars.

What is in this guide?

Every organization we can place at Festival of Biologics USA 2027: 107 speakers from the public program and speaker list (94 sessions so far) rolled up to their companies and institutions, plus the 42 sponsors and exhibitors from the public listing — 126 organizations in one list. Speakers appear as job titles, never by name.

How are organizations typed?

By the role an organization plays in biologics development: drug developers (large pharma and biotech), then the companies around them — CDMOs and CROs, bioprocess equipment and consumables, reagents and discovery tools, instruments and analytics, software and AI, consulting and other services — and academic, government and non-profit bodies. The topic filters come from the track a session sits in, and for keynotes from the session’s own title and description.

How current is it?

Pulled from the public agenda, speaker list and sponsor and exhibitor listing on October 15, 2026, six months before the meeting. The agenda is still filling in, so more sessions and speakers will follow. The organizer has not published a floor plan yet, so no stand numbers are shown, and the exhibition’s opening hours are not published either.

Browse Festival of Biologics USA 2027 by

Organization type

Topic

Exhibit hall

Exhibitors 42

Everyone

All organizations A–Z 126

Organizations with their own page

56 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by the Festival of Biologics or its organizers. Submit a correction